Review




Structured Review

Proteintech tfdp1
Fig. 3 In vitro CRISPR/Cas9-mediated screen to identify E2F members important for HSPC expansion. A FACS analysis of the percentage of GFP+ (Cas9+) cells within the mCherry+ (sgRNA+) and mCherry- (sgRNA-) HSPCs on day two (top) and six (bottom) post transduction. B Heatmap of survival/proliferation scores in HSPCs treated with the indicated sgRNAs (n = 2, biological replicates). The color indicates decreased (orange) and increased (blue) survival/proliferation scores. C Western blot of <t>TFDP1</t> and E2F4 three days post targeting with sgRNAs against Tfdp1 and E2f4. SgRosa26-1 was used as a negative control. Actin was used as a loading control. D Co-immunoprecipitation (Co-IP) using TFDP1 (top) and E2F4 as precipitating antibody (bottom) (n = 2, biological replicates).
Tfdp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/pm39043964-76-0-19?v=Proteintech
Average 92 stars, based on 3 article reviews
tfdp1 - by Bioz Stars, 2026-07
92/100 stars

Images

1) Product Images from "In vivo CRISPR/Cas9-mediated screen reveals a critical function of TFDP1 and E2F4 transcription factors in hematopoiesis."

Article Title: In vivo CRISPR/Cas9-mediated screen reveals a critical function of TFDP1 and E2F4 transcription factors in hematopoiesis.

Journal: Leukemia

doi: 10.1038/s41375-024-02357-w

Fig. 3 In vitro CRISPR/Cas9-mediated screen to identify E2F members important for HSPC expansion. A FACS analysis of the percentage of GFP+ (Cas9+) cells within the mCherry+ (sgRNA+) and mCherry- (sgRNA-) HSPCs on day two (top) and six (bottom) post transduction. B Heatmap of survival/proliferation scores in HSPCs treated with the indicated sgRNAs (n = 2, biological replicates). The color indicates decreased (orange) and increased (blue) survival/proliferation scores. C Western blot of TFDP1 and E2F4 three days post targeting with sgRNAs against Tfdp1 and E2f4. SgRosa26-1 was used as a negative control. Actin was used as a loading control. D Co-immunoprecipitation (Co-IP) using TFDP1 (top) and E2F4 as precipitating antibody (bottom) (n = 2, biological replicates).
Figure Legend Snippet: Fig. 3 In vitro CRISPR/Cas9-mediated screen to identify E2F members important for HSPC expansion. A FACS analysis of the percentage of GFP+ (Cas9+) cells within the mCherry+ (sgRNA+) and mCherry- (sgRNA-) HSPCs on day two (top) and six (bottom) post transduction. B Heatmap of survival/proliferation scores in HSPCs treated with the indicated sgRNAs (n = 2, biological replicates). The color indicates decreased (orange) and increased (blue) survival/proliferation scores. C Western blot of TFDP1 and E2F4 three days post targeting with sgRNAs against Tfdp1 and E2f4. SgRosa26-1 was used as a negative control. Actin was used as a loading control. D Co-immunoprecipitation (Co-IP) using TFDP1 (top) and E2F4 as precipitating antibody (bottom) (n = 2, biological replicates).

Techniques Used: In Vitro, CRISPR, Transduction, Western Blot, Negative Control, Control, Immunoprecipitation, Co-Immunoprecipitation Assay

Fig. 5 TFDP1 and E2F4 regulate HSPC proliferation, but not apoptosis. A Scheme of assessment of HSPC proliferation and apoptosis. Cas9- HSPCs were labeled with Celltrace, cultured for one day and transduced with lentiviral particles expressing sgRNAs targeting Tfdp1, E2f4, or the Rosa26. B Representative FACS analysis of the percentages of Annexin V+DAPI- (early) and Annexin V+DAPI+ (late) apoptotic cells within mCherry- (sgRNA-, upper panel) or mCherry+ (sgRNA+, lower panel) HSPCs treated with the indicated sgRNAs. C Representative FACS analysis of active Caspase 3+ apoptotic HSPCs treated with the indicated sgRNAs three days post puromycin selection (top) and summary of the data (bottom) based on HSPCs from three mice (n = 3). D Representative FACS analysis of the proliferation rates of mCherry- (sgRNA-) and mCherry+ (sgRNA+) HSPCs infected with the indicated sgRNAs two and four days post cell-trace labeling. The number of cell divisions is indicated. E Percentage of cell division in mCherry+ (upper) and mCherry- (below) HSPC subpopulations treated with the indicated sgRNAs on day two and day four post cell-trace labeling (n = 3 independent experiments).
Figure Legend Snippet: Fig. 5 TFDP1 and E2F4 regulate HSPC proliferation, but not apoptosis. A Scheme of assessment of HSPC proliferation and apoptosis. Cas9- HSPCs were labeled with Celltrace, cultured for one day and transduced with lentiviral particles expressing sgRNAs targeting Tfdp1, E2f4, or the Rosa26. B Representative FACS analysis of the percentages of Annexin V+DAPI- (early) and Annexin V+DAPI+ (late) apoptotic cells within mCherry- (sgRNA-, upper panel) or mCherry+ (sgRNA+, lower panel) HSPCs treated with the indicated sgRNAs. C Representative FACS analysis of active Caspase 3+ apoptotic HSPCs treated with the indicated sgRNAs three days post puromycin selection (top) and summary of the data (bottom) based on HSPCs from three mice (n = 3). D Representative FACS analysis of the proliferation rates of mCherry- (sgRNA-) and mCherry+ (sgRNA+) HSPCs infected with the indicated sgRNAs two and four days post cell-trace labeling. The number of cell divisions is indicated. E Percentage of cell division in mCherry+ (upper) and mCherry- (below) HSPC subpopulations treated with the indicated sgRNAs on day two and day four post cell-trace labeling (n = 3 independent experiments).

Techniques Used: Labeling, Cell Culture, Transduction, Expressing, Selection, Infection

Fig. 6 Transcriptional regulation of TFDP1 in HSPCs. A Experimental scheme of the RNA-seq experiment in Tfdp1-KO HSPCs. As a negative control, sgRosa26 was used. B Volcano plot depicting changes in gene expression in Tfdp1-KO HSPCs; y-axis represents the log10 transformation of the adjusted p value and x-axis the log2 transformation of the fold change. Red and blue dots represent up and downregulated genes, respectively. REACTOME pathway (C) and transcription factor enrichment analysis (D) of the downregulated genes in Tfdp1-KO HSPCs. The bubble plots depict the top 10 most significantly enriched gene sets. The bubble size corresponds to the number of genes and the color intensity reflects the adj. p value for each geneset. The total number of genes found within each dataset and the number of genes present in the downregulated genes are shown on the right.
Figure Legend Snippet: Fig. 6 Transcriptional regulation of TFDP1 in HSPCs. A Experimental scheme of the RNA-seq experiment in Tfdp1-KO HSPCs. As a negative control, sgRosa26 was used. B Volcano plot depicting changes in gene expression in Tfdp1-KO HSPCs; y-axis represents the log10 transformation of the adjusted p value and x-axis the log2 transformation of the fold change. Red and blue dots represent up and downregulated genes, respectively. REACTOME pathway (C) and transcription factor enrichment analysis (D) of the downregulated genes in Tfdp1-KO HSPCs. The bubble plots depict the top 10 most significantly enriched gene sets. The bubble size corresponds to the number of genes and the color intensity reflects the adj. p value for each geneset. The total number of genes found within each dataset and the number of genes present in the downregulated genes are shown on the right.

Techniques Used: RNA Sequencing, Negative Control, Gene Expression, Transformation Assay

Fig. 7 Meta-analysis of the role of TFDP1 and E2F4 in gene activation in mouse HSPCs. A Venn diagrams depicting the overlap between the differentially expressed genes in Tfdp1-KO HSPCs (downregulated genes in blue and upregulated genes in red) and human TFDP1- (left; GSE80661; GSE105217; GSE127368), human E2F4- (middle; GSE31477; GSE170651), and mouse E2F4- (right; GSE48666) bound target genes. B Intersection between human TFDP1- and E2F4-bound genes downregulated in Tfdp1-KO HSPCs. C Density plots (upper panel) and heatmaps (lower panel) depicting the average tag densities around TSSs (−2/+2 kb) of up- and downregulated genes in Tfdp1 KO HSPCs. Data are derived from the ChIP-seq of RNA polymerase II S5P (RnapolII S5P; GSE34518), H3K4Me3 (GSE75426), and E2F4 (GSE48666) (together with a negative control) in mouse ES cells. Right panel: ATAC-seq signals (GSE100738) from mouse short-term (ST) HSCs in the same genomic regions. D Example of RnapolII S5P, H3K4Me3, E2F4 tracks in mouse ES cells and ATAC-seq in ST-HSCs at the mouse Cdk1 locus. E Example of E2F4 and TFDP1 ChIP-seq signals at the CDK1 locus in various human cell types. Mouse and human E2F4 and TFDP1 DNA binding sites derived from the Unibind database are shown and the core nucleotides involved in DNA binding are highlighted.
Figure Legend Snippet: Fig. 7 Meta-analysis of the role of TFDP1 and E2F4 in gene activation in mouse HSPCs. A Venn diagrams depicting the overlap between the differentially expressed genes in Tfdp1-KO HSPCs (downregulated genes in blue and upregulated genes in red) and human TFDP1- (left; GSE80661; GSE105217; GSE127368), human E2F4- (middle; GSE31477; GSE170651), and mouse E2F4- (right; GSE48666) bound target genes. B Intersection between human TFDP1- and E2F4-bound genes downregulated in Tfdp1-KO HSPCs. C Density plots (upper panel) and heatmaps (lower panel) depicting the average tag densities around TSSs (−2/+2 kb) of up- and downregulated genes in Tfdp1 KO HSPCs. Data are derived from the ChIP-seq of RNA polymerase II S5P (RnapolII S5P; GSE34518), H3K4Me3 (GSE75426), and E2F4 (GSE48666) (together with a negative control) in mouse ES cells. Right panel: ATAC-seq signals (GSE100738) from mouse short-term (ST) HSCs in the same genomic regions. D Example of RnapolII S5P, H3K4Me3, E2F4 tracks in mouse ES cells and ATAC-seq in ST-HSCs at the mouse Cdk1 locus. E Example of E2F4 and TFDP1 ChIP-seq signals at the CDK1 locus in various human cell types. Mouse and human E2F4 and TFDP1 DNA binding sites derived from the Unibind database are shown and the core nucleotides involved in DNA binding are highlighted.

Techniques Used: Activation Assay, Derivative Assay, ChIP-sequencing, Negative Control, Binding Assay



Similar Products

93
Santa Cruz Biotechnology anti tfdp1
Anti Tfdp1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/pm40300683-109-7-10?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
anti tfdp1 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology immunohistochemical ihc staining for tfdp1
Immunohistochemical Ihc Staining For Tfdp1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/pm40300683-150-0-7?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
immunohistochemical ihc staining for tfdp1 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Shanghai GenePharma sirna-tfdp1
Sirna Tfdp1, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/pm39672972-59-13-27?v=Shanghai+GenePharma
Average 90 stars, based on 1 article reviews
sirna-tfdp1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Ribobio co si-tfdp1
( A ) Online prediction of binding sites between <t>TFDP1</t> and CKAP2 promoter sequences through JASPAR ( https://jaspar.genereg.net/ ). ( B, C ) The interaction between TFDP1 and CKAP2 in HCT116 and SW480 cells was confirmed using dual luciferase reporter assay and co-immunoprecipitation assay. ( D ) GEPIA online analysis of the correlation between the TFDP1 and CKAP2 expression levels in COAD (Colon adenocarcinoma) and READ (Rectum adenocarcinoma) databases. ( E ) Western blotting could detect protein levels of TFDP1 and CKAP2 in HCT116 and SW480 cells. ( F ) Western blotting could detect protein levels of TFDP1 and CKAP2 in HCT116 and SW480 cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Each experiment was executed in triplicate.
Si Tfdp1, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/pmc11637825-31-8-1?v=Ribobio+co
Average 90 stars, based on 1 article reviews
si-tfdp1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Thermo Fisher rabbit anti-tfdp1 pa5-86135
( A ) Online prediction of binding sites between <t>TFDP1</t> and CKAP2 promoter sequences through JASPAR ( https://jaspar.genereg.net/ ). ( B, C ) The interaction between TFDP1 and CKAP2 in HCT116 and SW480 cells was confirmed using dual luciferase reporter assay and co-immunoprecipitation assay. ( D ) GEPIA online analysis of the correlation between the TFDP1 and CKAP2 expression levels in COAD (Colon adenocarcinoma) and READ (Rectum adenocarcinoma) databases. ( E ) Western blotting could detect protein levels of TFDP1 and CKAP2 in HCT116 and SW480 cells. ( F ) Western blotting could detect protein levels of TFDP1 and CKAP2 in HCT116 and SW480 cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Each experiment was executed in triplicate.
Rabbit Anti Tfdp1 Pa5 86135, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/pm39043964-80-10-12?v=Thermo+Fisher
Average 90 stars, based on 1 article reviews
rabbit anti-tfdp1 pa5-86135 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

92
Proteintech tfdp1
Fig. 3 In vitro CRISPR/Cas9-mediated screen to identify E2F members important for HSPC expansion. A FACS analysis of the percentage of GFP+ (Cas9+) cells within the mCherry+ (sgRNA+) and mCherry- (sgRNA-) HSPCs on day two (top) and six (bottom) post transduction. B Heatmap of survival/proliferation scores in HSPCs treated with the indicated sgRNAs (n = 2, biological replicates). The color indicates decreased (orange) and increased (blue) survival/proliferation scores. C Western blot of <t>TFDP1</t> and E2F4 three days post targeting with sgRNAs against Tfdp1 and E2f4. SgRosa26-1 was used as a negative control. Actin was used as a loading control. D Co-immunoprecipitation (Co-IP) using TFDP1 (top) and E2F4 as precipitating antibody (bottom) (n = 2, biological replicates).
Tfdp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/pm39043964-76-0-19?v=Proteintech
Average 92 stars, based on 1 article reviews
tfdp1 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

90
Thermo Fisher mouse anti-tfdp1
Fig. 3 In vitro CRISPR/Cas9-mediated screen to identify E2F members important for HSPC expansion. A FACS analysis of the percentage of GFP+ (Cas9+) cells within the mCherry+ (sgRNA+) and mCherry- (sgRNA-) HSPCs on day two (top) and six (bottom) post transduction. B Heatmap of survival/proliferation scores in HSPCs treated with the indicated sgRNAs (n = 2, biological replicates). The color indicates decreased (orange) and increased (blue) survival/proliferation scores. C Western blot of <t>TFDP1</t> and E2F4 three days post targeting with sgRNAs against Tfdp1 and E2f4. SgRosa26-1 was used as a negative control. Actin was used as a loading control. D Co-immunoprecipitation (Co-IP) using TFDP1 (top) and E2F4 as precipitating antibody (bottom) (n = 2, biological replicates).
Mouse Anti Tfdp1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/pm39043964-76-11-13?v=Thermo+Fisher
Average 90 stars, based on 1 article reviews
mouse anti-tfdp1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

92
OriGene rabbit polyclonal igg dp1
Fig. 3 In vitro CRISPR/Cas9-mediated screen to identify E2F members important for HSPC expansion. A FACS analysis of the percentage of GFP+ (Cas9+) cells within the mCherry+ (sgRNA+) and mCherry- (sgRNA-) HSPCs on day two (top) and six (bottom) post transduction. B Heatmap of survival/proliferation scores in HSPCs treated with the indicated sgRNAs (n = 2, biological replicates). The color indicates decreased (orange) and increased (blue) survival/proliferation scores. C Western blot of <t>TFDP1</t> and E2F4 three days post targeting with sgRNAs against Tfdp1 and E2f4. SgRosa26-1 was used as a negative control. Actin was used as a loading control. D Co-immunoprecipitation (Co-IP) using TFDP1 (top) and E2F4 as precipitating antibody (bottom) (n = 2, biological replicates).
Rabbit Polyclonal Igg Dp1, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/pm38522129-62-49-66?v=OriGene
Average 92 stars, based on 1 article reviews
rabbit polyclonal igg dp1 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

86
Danaher Inc anti tfdp1 antibody
Fig. 3 In vitro CRISPR/Cas9-mediated screen to identify E2F members important for HSPC expansion. A FACS analysis of the percentage of GFP+ (Cas9+) cells within the mCherry+ (sgRNA+) and mCherry- (sgRNA-) HSPCs on day two (top) and six (bottom) post transduction. B Heatmap of survival/proliferation scores in HSPCs treated with the indicated sgRNAs (n = 2, biological replicates). The color indicates decreased (orange) and increased (blue) survival/proliferation scores. C Western blot of <t>TFDP1</t> and E2F4 three days post targeting with sgRNAs against Tfdp1 and E2f4. SgRosa26-1 was used as a negative control. Actin was used as a loading control. D Co-immunoprecipitation (Co-IP) using TFDP1 (top) and E2F4 as precipitating antibody (bottom) (n = 2, biological replicates).
Anti Tfdp1 Antibody, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tfdp1/ppr0828358-54-11-14?v=Danaher+Inc
Average 86 stars, based on 1 article reviews
anti tfdp1 antibody - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


( A ) Online prediction of binding sites between TFDP1 and CKAP2 promoter sequences through JASPAR ( https://jaspar.genereg.net/ ). ( B, C ) The interaction between TFDP1 and CKAP2 in HCT116 and SW480 cells was confirmed using dual luciferase reporter assay and co-immunoprecipitation assay. ( D ) GEPIA online analysis of the correlation between the TFDP1 and CKAP2 expression levels in COAD (Colon adenocarcinoma) and READ (Rectum adenocarcinoma) databases. ( E ) Western blotting could detect protein levels of TFDP1 and CKAP2 in HCT116 and SW480 cells. ( F ) Western blotting could detect protein levels of TFDP1 and CKAP2 in HCT116 and SW480 cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Each experiment was executed in triplicate.

Journal: Journal of Microbiology and Biotechnology

Article Title: CKAP2 Regulated by TFDP1 Promotes Metastasis and Proliferation of Colorectal Cancer through Affecting the Tumor Microenvironment

doi: 10.4014/jmb.2407.07008

Figure Lengend Snippet: ( A ) Online prediction of binding sites between TFDP1 and CKAP2 promoter sequences through JASPAR ( https://jaspar.genereg.net/ ). ( B, C ) The interaction between TFDP1 and CKAP2 in HCT116 and SW480 cells was confirmed using dual luciferase reporter assay and co-immunoprecipitation assay. ( D ) GEPIA online analysis of the correlation between the TFDP1 and CKAP2 expression levels in COAD (Colon adenocarcinoma) and READ (Rectum adenocarcinoma) databases. ( E ) Western blotting could detect protein levels of TFDP1 and CKAP2 in HCT116 and SW480 cells. ( F ) Western blotting could detect protein levels of TFDP1 and CKAP2 in HCT116 and SW480 cells. * p < 0.05, ** p < 0.01, *** p < 0.001. Each experiment was executed in triplicate.

Article Snippet: Plasmids (RiboBio, China), including sh-CKAP2, sh-NC, pcDNA3.1-CKAP2, pcDNA3.1-NC, si-TFDP1, and si-NC were used.

Techniques: Binding Assay, Luciferase, Reporter Assay, Co-Immunoprecipitation Assay, Expressing, Western Blot

( A ) The CKAP2 protein level in different groups (si-NC, si-TFDP1, si-TFDP1+pcDNA-CKAP2) of HCT116 and SW480 cells was detected by western blotting. ( B ) The proliferation of HCT116 and SW480 cells was assessed by EdU assay. ( C ) Transwell assay was conducted to detect the migration ability of HCT116 and SW480 cells. ( D ) Transwell assay was conducted to detect the invasion ability of HCT116 and SW480 cells. * p < 0.05, ** p < 0.01, *** p < 0.001. # p < 0.05, ## p < 0.01, ### p < 0.001. Each experiment was executed in triplicate.

Journal: Journal of Microbiology and Biotechnology

Article Title: CKAP2 Regulated by TFDP1 Promotes Metastasis and Proliferation of Colorectal Cancer through Affecting the Tumor Microenvironment

doi: 10.4014/jmb.2407.07008

Figure Lengend Snippet: ( A ) The CKAP2 protein level in different groups (si-NC, si-TFDP1, si-TFDP1+pcDNA-CKAP2) of HCT116 and SW480 cells was detected by western blotting. ( B ) The proliferation of HCT116 and SW480 cells was assessed by EdU assay. ( C ) Transwell assay was conducted to detect the migration ability of HCT116 and SW480 cells. ( D ) Transwell assay was conducted to detect the invasion ability of HCT116 and SW480 cells. * p < 0.05, ** p < 0.01, *** p < 0.001. # p < 0.05, ## p < 0.01, ### p < 0.001. Each experiment was executed in triplicate.

Article Snippet: Plasmids (RiboBio, China), including sh-CKAP2, sh-NC, pcDNA3.1-CKAP2, pcDNA3.1-NC, si-TFDP1, and si-NC were used.

Techniques: Western Blot, EdU Assay, Transwell Assay, Migration

Fig. 3 In vitro CRISPR/Cas9-mediated screen to identify E2F members important for HSPC expansion. A FACS analysis of the percentage of GFP+ (Cas9+) cells within the mCherry+ (sgRNA+) and mCherry- (sgRNA-) HSPCs on day two (top) and six (bottom) post transduction. B Heatmap of survival/proliferation scores in HSPCs treated with the indicated sgRNAs (n = 2, biological replicates). The color indicates decreased (orange) and increased (blue) survival/proliferation scores. C Western blot of TFDP1 and E2F4 three days post targeting with sgRNAs against Tfdp1 and E2f4. SgRosa26-1 was used as a negative control. Actin was used as a loading control. D Co-immunoprecipitation (Co-IP) using TFDP1 (top) and E2F4 as precipitating antibody (bottom) (n = 2, biological replicates).

Journal: Leukemia

Article Title: In vivo CRISPR/Cas9-mediated screen reveals a critical function of TFDP1 and E2F4 transcription factors in hematopoiesis.

doi: 10.1038/s41375-024-02357-w

Figure Lengend Snippet: Fig. 3 In vitro CRISPR/Cas9-mediated screen to identify E2F members important for HSPC expansion. A FACS analysis of the percentage of GFP+ (Cas9+) cells within the mCherry+ (sgRNA+) and mCherry- (sgRNA-) HSPCs on day two (top) and six (bottom) post transduction. B Heatmap of survival/proliferation scores in HSPCs treated with the indicated sgRNAs (n = 2, biological replicates). The color indicates decreased (orange) and increased (blue) survival/proliferation scores. C Western blot of TFDP1 and E2F4 three days post targeting with sgRNAs against Tfdp1 and E2f4. SgRosa26-1 was used as a negative control. Actin was used as a loading control. D Co-immunoprecipitation (Co-IP) using TFDP1 (top) and E2F4 as precipitating antibody (bottom) (n = 2, biological replicates).

Article Snippet: TFDP1, E2F4, E2F1, and beta-Actin proteins were detected using primary antibodies: mouse anti-TFDP1 (Thermo Scientific, Cat# MA5-11268), mouse anti-E2F4 (Proteintech, Cat# 67812-1-Ig), rabbit anti-E2F4 (Sigma, Cat# AV31175), mouse anti-E2F1 (Proteintech, Cat# 66515-1-Ig) and mouse anti-β-Actin (Sigma-Aldrich Cat# A2228).

Techniques: In Vitro, CRISPR, Transduction, Western Blot, Negative Control, Control, Immunoprecipitation, Co-Immunoprecipitation Assay

Fig. 5 TFDP1 and E2F4 regulate HSPC proliferation, but not apoptosis. A Scheme of assessment of HSPC proliferation and apoptosis. Cas9- HSPCs were labeled with Celltrace, cultured for one day and transduced with lentiviral particles expressing sgRNAs targeting Tfdp1, E2f4, or the Rosa26. B Representative FACS analysis of the percentages of Annexin V+DAPI- (early) and Annexin V+DAPI+ (late) apoptotic cells within mCherry- (sgRNA-, upper panel) or mCherry+ (sgRNA+, lower panel) HSPCs treated with the indicated sgRNAs. C Representative FACS analysis of active Caspase 3+ apoptotic HSPCs treated with the indicated sgRNAs three days post puromycin selection (top) and summary of the data (bottom) based on HSPCs from three mice (n = 3). D Representative FACS analysis of the proliferation rates of mCherry- (sgRNA-) and mCherry+ (sgRNA+) HSPCs infected with the indicated sgRNAs two and four days post cell-trace labeling. The number of cell divisions is indicated. E Percentage of cell division in mCherry+ (upper) and mCherry- (below) HSPC subpopulations treated with the indicated sgRNAs on day two and day four post cell-trace labeling (n = 3 independent experiments).

Journal: Leukemia

Article Title: In vivo CRISPR/Cas9-mediated screen reveals a critical function of TFDP1 and E2F4 transcription factors in hematopoiesis.

doi: 10.1038/s41375-024-02357-w

Figure Lengend Snippet: Fig. 5 TFDP1 and E2F4 regulate HSPC proliferation, but not apoptosis. A Scheme of assessment of HSPC proliferation and apoptosis. Cas9- HSPCs were labeled with Celltrace, cultured for one day and transduced with lentiviral particles expressing sgRNAs targeting Tfdp1, E2f4, or the Rosa26. B Representative FACS analysis of the percentages of Annexin V+DAPI- (early) and Annexin V+DAPI+ (late) apoptotic cells within mCherry- (sgRNA-, upper panel) or mCherry+ (sgRNA+, lower panel) HSPCs treated with the indicated sgRNAs. C Representative FACS analysis of active Caspase 3+ apoptotic HSPCs treated with the indicated sgRNAs three days post puromycin selection (top) and summary of the data (bottom) based on HSPCs from three mice (n = 3). D Representative FACS analysis of the proliferation rates of mCherry- (sgRNA-) and mCherry+ (sgRNA+) HSPCs infected with the indicated sgRNAs two and four days post cell-trace labeling. The number of cell divisions is indicated. E Percentage of cell division in mCherry+ (upper) and mCherry- (below) HSPC subpopulations treated with the indicated sgRNAs on day two and day four post cell-trace labeling (n = 3 independent experiments).

Article Snippet: TFDP1, E2F4, E2F1, and beta-Actin proteins were detected using primary antibodies: mouse anti-TFDP1 (Thermo Scientific, Cat# MA5-11268), mouse anti-E2F4 (Proteintech, Cat# 67812-1-Ig), rabbit anti-E2F4 (Sigma, Cat# AV31175), mouse anti-E2F1 (Proteintech, Cat# 66515-1-Ig) and mouse anti-β-Actin (Sigma-Aldrich Cat# A2228).

Techniques: Labeling, Cell Culture, Transduction, Expressing, Selection, Infection

Fig. 6 Transcriptional regulation of TFDP1 in HSPCs. A Experimental scheme of the RNA-seq experiment in Tfdp1-KO HSPCs. As a negative control, sgRosa26 was used. B Volcano plot depicting changes in gene expression in Tfdp1-KO HSPCs; y-axis represents the log10 transformation of the adjusted p value and x-axis the log2 transformation of the fold change. Red and blue dots represent up and downregulated genes, respectively. REACTOME pathway (C) and transcription factor enrichment analysis (D) of the downregulated genes in Tfdp1-KO HSPCs. The bubble plots depict the top 10 most significantly enriched gene sets. The bubble size corresponds to the number of genes and the color intensity reflects the adj. p value for each geneset. The total number of genes found within each dataset and the number of genes present in the downregulated genes are shown on the right.

Journal: Leukemia

Article Title: In vivo CRISPR/Cas9-mediated screen reveals a critical function of TFDP1 and E2F4 transcription factors in hematopoiesis.

doi: 10.1038/s41375-024-02357-w

Figure Lengend Snippet: Fig. 6 Transcriptional regulation of TFDP1 in HSPCs. A Experimental scheme of the RNA-seq experiment in Tfdp1-KO HSPCs. As a negative control, sgRosa26 was used. B Volcano plot depicting changes in gene expression in Tfdp1-KO HSPCs; y-axis represents the log10 transformation of the adjusted p value and x-axis the log2 transformation of the fold change. Red and blue dots represent up and downregulated genes, respectively. REACTOME pathway (C) and transcription factor enrichment analysis (D) of the downregulated genes in Tfdp1-KO HSPCs. The bubble plots depict the top 10 most significantly enriched gene sets. The bubble size corresponds to the number of genes and the color intensity reflects the adj. p value for each geneset. The total number of genes found within each dataset and the number of genes present in the downregulated genes are shown on the right.

Article Snippet: TFDP1, E2F4, E2F1, and beta-Actin proteins were detected using primary antibodies: mouse anti-TFDP1 (Thermo Scientific, Cat# MA5-11268), mouse anti-E2F4 (Proteintech, Cat# 67812-1-Ig), rabbit anti-E2F4 (Sigma, Cat# AV31175), mouse anti-E2F1 (Proteintech, Cat# 66515-1-Ig) and mouse anti-β-Actin (Sigma-Aldrich Cat# A2228).

Techniques: RNA Sequencing, Negative Control, Gene Expression, Transformation Assay

Fig. 7 Meta-analysis of the role of TFDP1 and E2F4 in gene activation in mouse HSPCs. A Venn diagrams depicting the overlap between the differentially expressed genes in Tfdp1-KO HSPCs (downregulated genes in blue and upregulated genes in red) and human TFDP1- (left; GSE80661; GSE105217; GSE127368), human E2F4- (middle; GSE31477; GSE170651), and mouse E2F4- (right; GSE48666) bound target genes. B Intersection between human TFDP1- and E2F4-bound genes downregulated in Tfdp1-KO HSPCs. C Density plots (upper panel) and heatmaps (lower panel) depicting the average tag densities around TSSs (−2/+2 kb) of up- and downregulated genes in Tfdp1 KO HSPCs. Data are derived from the ChIP-seq of RNA polymerase II S5P (RnapolII S5P; GSE34518), H3K4Me3 (GSE75426), and E2F4 (GSE48666) (together with a negative control) in mouse ES cells. Right panel: ATAC-seq signals (GSE100738) from mouse short-term (ST) HSCs in the same genomic regions. D Example of RnapolII S5P, H3K4Me3, E2F4 tracks in mouse ES cells and ATAC-seq in ST-HSCs at the mouse Cdk1 locus. E Example of E2F4 and TFDP1 ChIP-seq signals at the CDK1 locus in various human cell types. Mouse and human E2F4 and TFDP1 DNA binding sites derived from the Unibind database are shown and the core nucleotides involved in DNA binding are highlighted.

Journal: Leukemia

Article Title: In vivo CRISPR/Cas9-mediated screen reveals a critical function of TFDP1 and E2F4 transcription factors in hematopoiesis.

doi: 10.1038/s41375-024-02357-w

Figure Lengend Snippet: Fig. 7 Meta-analysis of the role of TFDP1 and E2F4 in gene activation in mouse HSPCs. A Venn diagrams depicting the overlap between the differentially expressed genes in Tfdp1-KO HSPCs (downregulated genes in blue and upregulated genes in red) and human TFDP1- (left; GSE80661; GSE105217; GSE127368), human E2F4- (middle; GSE31477; GSE170651), and mouse E2F4- (right; GSE48666) bound target genes. B Intersection between human TFDP1- and E2F4-bound genes downregulated in Tfdp1-KO HSPCs. C Density plots (upper panel) and heatmaps (lower panel) depicting the average tag densities around TSSs (−2/+2 kb) of up- and downregulated genes in Tfdp1 KO HSPCs. Data are derived from the ChIP-seq of RNA polymerase II S5P (RnapolII S5P; GSE34518), H3K4Me3 (GSE75426), and E2F4 (GSE48666) (together with a negative control) in mouse ES cells. Right panel: ATAC-seq signals (GSE100738) from mouse short-term (ST) HSCs in the same genomic regions. D Example of RnapolII S5P, H3K4Me3, E2F4 tracks in mouse ES cells and ATAC-seq in ST-HSCs at the mouse Cdk1 locus. E Example of E2F4 and TFDP1 ChIP-seq signals at the CDK1 locus in various human cell types. Mouse and human E2F4 and TFDP1 DNA binding sites derived from the Unibind database are shown and the core nucleotides involved in DNA binding are highlighted.

Article Snippet: TFDP1, E2F4, E2F1, and beta-Actin proteins were detected using primary antibodies: mouse anti-TFDP1 (Thermo Scientific, Cat# MA5-11268), mouse anti-E2F4 (Proteintech, Cat# 67812-1-Ig), rabbit anti-E2F4 (Sigma, Cat# AV31175), mouse anti-E2F1 (Proteintech, Cat# 66515-1-Ig) and mouse anti-β-Actin (Sigma-Aldrich Cat# A2228).

Techniques: Activation Assay, Derivative Assay, ChIP-sequencing, Negative Control, Binding Assay